Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth

References

• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Chen Y, Klionsky DJ. The regulation of autophagy - unanswered questions. J. Cell Sci. 2011;124(Pt 2):161–170.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Ren X, Hait WN, et al. Therapeutic targeting of autophagy in disease: biology and pharmacology. Pharmacoll. Rev. 2013;65(4):1162–1197.
   PubMed Web of Science ®Google Scholar
• Wei H, Wei S, Gan B, et al. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev. 2011;25(14):1510–1527.
   PubMed Web of Science ®Google Scholar
• Yang A, Rajeshkumar NV, Wang X, et al. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 2014;4(8):905–913.
   PubMed Web of Science ®Google Scholar
• Poillet-Perez L, Xie X, Zhan L, et al. Autophagy maintains tumour growth through circulating arginine. Nature. 2018;563(7732):569–573.
   PubMed Web of Science ®Google Scholar
• Li Z, Tian X, Ji X, et al. ULK1-ATG13 and their mitotic phospho-regulation by CDK1 connect autophagy to cell cycle. PLoS Biol. 2020;18(6):e3000288.
   PubMed Web of Science ®Google Scholar
• Chen Y, Henson ES, Xiao W, et al. Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagyin hypoxia. Autophagy. 2016;12(6):1029–1046.
   PubMed Web of Science ®Google Scholar
• Lee MP, Brandenburg S, Landes GM, et al. Two novel genes in the center of the 11p15 imprinted domain escape genomic imprinting. Hum Mol Genet. 1999;8(4):683–690.
   PubMedGoogle Scholar
• Matsuoka S, Edwards MC, Bai C, et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995;9(6):650–662.
   PubMed Web of Science ®Google Scholar
• Dai H, Huang Y, Li Y, et al. TSSC3 over-expression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma. Carcinogenesis. 2012;33(1):30–40.
   PubMedGoogle Scholar
• Hao Y, Crenshaw T, Moulton T, et al. Tumour-suppressor activity of H19 RNA. Nature. 1993;365(6448):764–767.
   PubMed Web of Science ®Google Scholar
• Joyce JA, Schofield PN. Genomic imprinting and cancer. Mol Pathol. 1998;51(4):185–190.
   PubMedGoogle Scholar
• Prawitt D, Enklaar T, Klemm G, et al. Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression. Hum Mol Genet. 2000;9(2):203–216.
   PubMedGoogle Scholar
• Nature (https://www.nature.com/). Nature research. 2021. Available from: https://www.nature.com/subjects/cell-growth#~text=Cell%20growth%20usually%20refers%20to,the%20absence%20of%20cell%20division.
   Google Scholar
• Musgrove EA, Caldon CE, Barraclough J, et al. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer. 2011;11(8):558–572.
   PubMed Web of Science ®Google Scholar
• Juríková M, Danihel Ľ, Polák Š, et al. Ki67, PCNA, and MCM proteins: markers of proliferation in the diagnosis of breast cancer. Acta Histochem. 2016;118(5):544–552.
   PubMed Web of Science ®Google Scholar
• Karakuş F, Eyol E, Yılmaz K, et al. Inhibition of cell proliferation, migration and colony formation of LS174T Cells by carbonic anhydrase inhibitor. Afr Health Sci. 2018;18(4):1303–1310.
   PubMedGoogle Scholar
• Luo X, Shen S, Yi S, et al. Screening of differentially expressed miRNAs in tensile strain treated HepG2 cells by miRNA microarray analysis. Mol Med Rep. 2020;21(6):2415–2426.
   PubMed Web of Science ®Google Scholar
• Guo JY, White E. Autophagy, Metabolism, and Cancer. Cold Spring Harb Symp Quant Biol. 2016;81:73–78.
   PubMedGoogle Scholar
• Yoshii SR, Mizushima N. Monitoring and measuring autophagy. Int J Mol Sci. 2017;18(9):1865.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140(3):313–326.
   PubMed Web of Science ®Google Scholar
• Birgisdottir ÅB, Lamark T, Johansen T. The LIR motif - crucial for selective autophagy. J Cell Sci. 2013;126(Pt 15):3237–3247.
   PubMed Web of Science ®Google Scholar
• Wild P, McEwan DG, Dikic I. The LC3 interactome at a glance. J Cell Sci. 2014;127(Pt 1):3–9.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang R, Huang S, et al. Erb-b2 Receptor Tyrosine Kinase 2 (ERBB2) Promotes ATG12-Dependent Autophagy Contributing to Treatment Resistance of Breast Cancer Cells. Cancers (Basel). 2021;13(5):1038.
   PubMedGoogle Scholar
• Kirkin V, Lamark T, Sou YS, et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell. 2009;33(4):505–516.
   PubMed Web of Science ®Google Scholar
• Nollet EA, Cardo-Vila M, Ganguly SS, et al. Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer. Oncogene. 2020;39(31):5390–5404.
   PubMedGoogle Scholar
• Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009;23(5):537–548.
   PubMed Web of Science ®Google Scholar
• Senga SS, Grose RP. Hallmarks of cancer-the new testament. Open Biol. 2021;11(1):200358.
   PubMed Web of Science ®Google Scholar
• Hsu JL, Hung MC. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer. Cancer Metastasis Rev. 2016;35(4):575–588.
   PubMed Web of Science ®Google Scholar
• Keller S, Schmidt MHH. EGFR and EGFRvIII promote angiogenesis and cell invasion in glioblastoma: combination Therapies for an Effective Treatment. Int J Mol Sci. 2017;18(6):1295.
   Google Scholar
• Elstrom RL, Bauer DE, Buzzai M, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004;64(11):3892–3899.
   PubMed Web of Science ®Google Scholar
• Ma S, Henson ES, Chen Y, et al. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 2016;7(7):e2307.
   PubMed Web of Science ®Google Scholar
• Jiang B. Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes Dis. 2017;4(1):25–27.
   PubMed Web of Science ®Google Scholar
• Sonveaux P, Végran F, Schroeder T, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest. 2008;118(12):3930–3942.
   PubMed Web of Science ®Google Scholar
• Heinecke JL, Ridnour LA, Cheng RY, et al. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression. Proc Natl Acad Sci U S A. 2014;111(17):6323–6328.
   PubMedGoogle Scholar
• Lee SY, Ju MK, Jeon HM, et al. Regulation of tumor progression y programmed necrosis. Oxid Med Cell Longev. 2018;2018:3537471.
   PubMed Web of Science ®Google Scholar
• Tang MC, Wu MY, Hwang MH, et al. Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant non small cell lung cancer cells. Plos One. 2015;1093(3):e0119135.
   Google Scholar
• Zhang J, Mao S, Wang L, et al. MicroRNA 154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7. Oncol Rep. 2019;41(2):819–828.
   PubMedGoogle Scholar
• White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 2009;15(17):5308–5316.
   PubMed Web of Science ®Google Scholar
• Clarke PG, Puyal J. Autophagic cell death exists. Autophagy. 2012;8(6):867–869.
   PubMed Web of Science ®Google Scholar
• Chen Y, McMillan-Ward E, Kong J, et al. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci. 2007;120(Pt 23):4155–4166.
   PubMed Web of Science ®Google Scholar
• Chen Y, McMillan-Ward E, Kong J, et al. Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells. Cell Death Differ. 2008;15(1):171–182.
   PubMed Web of Science ®Google Scholar
• Azad MB, Chen Y, Henson ES, et al. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy. 2008;4(2):195–204.
   PubMed Web of Science ®Google Scholar
• Dey P, Kundu A, Sachan R, et al. PKM2 knockdown induces autophagic cell death via AKT/mTOR pathway in human prostate cancer cells. Cell Physiol Biochem. 2019;52(6):1535–1552.
   PubMedGoogle Scholar
• Chen P, Huang HP, Wang Y, et al. Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death. J Exp Clin Cancer Res. 2019;38(1):254.
   PubMedGoogle Scholar
• Wu B, Tan M, Cai W, et al. Arsenic trioxide induces autophagic cell death in osteosarcoma cells via the ROS-TFEB signaling pathway. Biochem. Biophys. Res. Commun. 2018;496(1):167–175.
   PubMedGoogle Scholar
• Kanzawa T, Zhang L, Xiao L, et al. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene. 2005;24(6):980–991.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Chi CW, Su WC, et al. Lapatinib induces autophagic cell death and inhibits growth of human hepatocellular carninoma. Oncotarget. 2014;5(13):4845–4854.
   PubMedGoogle Scholar
• He C, Levine B. The Beclin 1 interactome. Curr Opin Cell Biol. 2010;22(2):140–149.
   PubMed Web of Science ®Google Scholar
• Liang C. Negative regulation of autophagy. Cell Death Differ. 2010;17(12):1807–1815.
   PubMedGoogle Scholar
• Sarkar S. Regulation of autophagy by mTOR-dependent and mTOR-independentpathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers. Biochem Soc Trans. 2013;41(5):1103–1130.
   PubMedGoogle Scholar
• Liang XH, Kleeman LK, Jiang HH, et al. Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol. 1998;72(11):8586–8596.
   PubMed Web of Science ®Google Scholar
• Ganley IG, Lam Du H, Wang J, et al. ULK1.ATG13.FIP200 complex mediates mROR signaling and is essential for autophagy. J. Biol. Chem. 2009;284(18):12297–12305.
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–1991.
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20(7):1992–2003.
   PubMed Web of Science ®Google Scholar
• Egan DF, Shackelford DB, Mihaylova MM, et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science. 2011;331(6016):456–461.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Wang Z. ErbB receptors and cancer. Methods Mol Biol. 2017;1652:3–35.
   PubMedGoogle Scholar
• Iqbal N, Iqbal N. Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Mol. Biol. Int. 2014;2014:852748.
   PubMedGoogle Scholar
• Janser FA, Tschan MP, Langer R. The role of autophagy in HER2-targeted therapy. Swiss Med Wkly. 2019;149:w20138.
   PubMedGoogle Scholar
• Yu D, Hung MC. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene. 2000;19(53):6115–6121.
   PubMed Web of Science ®Google Scholar
• Yan M, Schwaederle M, Arguello D, et al. HER2 expression status in diverse cancers: review of results from 37,992 patients. Cancer Metastasis Rev. 2015;34(1):157–164.
   PubMed Web of Science ®Google Scholar
• Thomas R, Weihua Z. Rethink of EGFR in cancer with its kinase independent function on board. Front Oncol. 2019;9:800.
   PubMed Web of Science ®Google Scholar
• Gan HK, Cvrljevic AN, Johns TG. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. FEBS J. 2013;280(21):5350–5370.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chang A. Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer. Int J Med Sci. 2008;5(4):209–217.
   PubMedGoogle Scholar
• Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 2017;9(5):52.
   PubMed Web of Science ®Google Scholar
• Han J, Hou W, Lu C, et al. Interaction between Her2 and Beclin-1 proteins underlies a new mechanism of reciprocal regulation. J Biol Chem. 2013;288(28):20315–20325.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zou Z, Becker N, et al. EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell. 2013;154(6):1269–1284.
   PubMed Web of Science ®Google Scholar
• Jutten B, Keulers TG, Peeters HJM, et al. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition. Autophagy. 2018;14(2):283–295.
   PubMed Web of Science ®Google Scholar
• Fernández-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer. 2011;2(3):344–358.
   PubMedGoogle Scholar
• Gimple RC, Wang X. RAS: striking at the core of the oncogenic circuitry. Front Oncol. 2019;9:965.
   PubMedGoogle Scholar
• Schmukler E, Kloog Y, Pinkas-Kramarski R. Ras and autophagy in cancer development and therapy. Oncotarget. 2014;5(3):577–586.
   PubMedGoogle Scholar
• Chen H, Liu H, Qing G. Targeting oncogenic Myc as a strategy for cancer treatment. Signal Transduct Target Ther. 2018;3(1):5.
   PubMedGoogle Scholar
• Stine ZE, Walton ZE, Altman BJ, et al. MYC, metabolism, andcancer. Cancer Discov. 2015;5(10):1024–1039.
   PubMed Web of Science ®Google Scholar
• Chen Y, Azad MB, Gibson SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ. 2009;16(7):1040–1052.
   PubMed Web of Science ®Google Scholar
• Kothari S, Cizeau J, McMillan-Ward E, et al. BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene. 2003;22(30):4734–4744.
   PubMedGoogle Scholar
• Taylor SC, Berkelman T, Yadav G, et al. A defined methodology for reliable quantification of Western blot data. Mol Biotechnol. 2013;55(3):217–226.
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang Z, Bao W, et al. SNX10 (sorting nexin 10) inhibits colorectal cancer initiation and progression by controlling autophagic degradation of SRC. Autophagy. 2020;16(4):735–749.
   PubMed Web of Science ®Google Scholar
• Franken NA, Rodermond HM, Stap J, et al. Clonogenic assay of cells in vitro. Nat Protoc. 2006;1(5):2315–2319.
   PubMed Web of Science ®Google Scholar
• Burton TR, Henson ES, Azad MB, et al. BNIP3 acts as transcriptional repressor of death receptor-5 expression and prevents TRAIL-induced cell death in gliomas. Cell Death Dis. 2013;4(4):e587.
   PubMedGoogle Scholar
• Campbell RE, Tour O, Palmer AE, et al. A monomeric red fluorescent protein. Proc Natl Acad Sci U S A. 2002;99(12):7877–7882.
   PubMed Web of Science ®Google Scholar
• Li YM, Pan Y, Wei Y, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell. 2004;6(5):459–469.
   PubMed Web of Science ®Google Scholar
• Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 2015;111(1):A3.B.1–A3.B.3.
   PubMedGoogle Scholar
• Reuter J. Subcutaneous injection of tumor cells. Bio-101. 2011;e166.
   Google Scholar
• Chen Y, Wei H, Liu F, et al. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. J Biol Chem. 2014;289(2):1164–1173.
   PubMedGoogle Scholar